Yükleniyor... / Loading...
This study examined the value of the T1 mapping method used in MRI in patients with Fabry disease. It included adults with confirmed Fabry disease and, for comparison, control patients undergoing kidney assessment for other reasons. It was a study without an assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Patient with confirmed Fabry disease Or Control patients: Patients undergoing renal functional exploration for a reason other than Fabry disease, amyloidosis, hemochromatosis * Adult patient * Patient informed of the study and agree to participate * Patient affiliated to a social security or beneficiaries of a similar scheme Exclusion Criteria: * Weight \> 130 kg * kidney transplant, * polycystic kidney disease, * Pregnant, parturient or breastfeeding * Contraindications to MRI * Subject participating in another research including an exclusion period still in progress at inclusion * Persons deprived of their liberty by a judicial or administrative decision, * Adults subject to a legal protection measure (safeguard measure, guardianship, curators)